His Existence Questioned

The Jan. 8, 1996, issue of The Scientist contains a letter that seems to say, if I understand it correctly, that I do not exist [G.H. Scherr, page 12]. The letter concerns the Annals of Improbable Research (AIR) and the publication I used to edit, the Journal of Irreproducible Results (JIR). I was especially surprised and delighted to read that "neither Abrahams nor the AIR were ever associated with the Ig Nobel Prize." In 1991, I created and hosted the (now) annual Ig Nobel Prize ceremonies,

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I was especially surprised and delighted to read that "neither Abrahams nor the AIR were ever associated with the Ig Nobel Prize." In 1991, I created and hosted the (now) annual Ig Nobel Prize ceremonies, which were held at the Massachusetts Institute of Technology for the first four years and at Harvard University this past October.

Scherr also says that he was "the editor" of JIR "during the entire period" of JIR's existence. 'Taint so on either count. A look at the old JIR mastheads (available in any fine library) shows that Alexander Kohn and Harry Lipkin founded JIR in 1955 and were its coeditors until 1964. Alex was JIR's sole editor from 1964 to 1989. I served in that role from 1990 to 1994. Scherr's association with JIR didn't begin until 1964, when he bought the trademark and became the "publisher"; in 1989, he sold the journal to another ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Marc Abrahams

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide